Yunfeng Tong
YOU?
Author Swipe
View article: Treatment‐Related Adverse Events of Antibody‐Drug Conjugate Monotherapy in Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis
Treatment‐Related Adverse Events of Antibody‐Drug Conjugate Monotherapy in Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis Open
Background Antibody‐drug conjugates (ADCs) have demonstrated promising efficacy in several prospective clinical studies, offering new possibilities for the treatment of non‐small cell lung cancer (NSCLC). Consequently, understanding the to…
View article: Decoding the tumor immune microenvironment in lung squamous cell carcinoma: characteristics, regulatory mechanisms, and future directions in immunotherapy
Decoding the tumor immune microenvironment in lung squamous cell carcinoma: characteristics, regulatory mechanisms, and future directions in immunotherapy Open
Lung squamous cell carcinoma (LUSC), a predominant type of lung cancer, is marked by an unfavorable prognosis and limited therapeutic options. Unlike lung adenocarcinoma (LUAD), LUSC exhibits few driver mutations, resulting in minimal bene…
View article: Development of a deep learning model for T1N0 gastric cancer diagnosis using 2.5D radiomic data in preoperative CT images
Development of a deep learning model for T1N0 gastric cancer diagnosis using 2.5D radiomic data in preoperative CT images Open
Early detection and precise preoperative staging of early gastric cancer (EGC) are critical. Therefore, this study aims to develop a deep learning model using portal venous phase CT images to accurately distinguish EGC without lymph node m…
View article: Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis
Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis Open
Background: Immune checkpoint inhibitors (ICIs) combined with chemotherapy, with or without angiogenesis inhibitors, have been investigated as the first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC). However, it remai…
View article: A four gene risk score model for prognosis and immune microenvironment insights in small cell lung cancer based on CAF functional-related genes
A four gene risk score model for prognosis and immune microenvironment insights in small cell lung cancer based on CAF functional-related genes Open
Small cell lung cancer (SCLC) is still one of the most formidable challenges in oncology. In this study, we introduce an innovative risk scoring model rooted in cancer-associated fibroblast (CAF)-related functional genes, designed to predi…
View article: Effect of Psychological Nursing Combined with Health Education on the Quality of Life of Patients with Lung Cancer
Effect of Psychological Nursing Combined with Health Education on the Quality of Life of Patients with Lung Cancer Open
Objective: To analyze the effect of psychological nursing combined with health education on the quality of life of patients with lung cancer. Methods: 80 patients with lung cancer admitted to our hospital’s Department of Cardiothoracic Sur…
View article: Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity Open
Chimeric antigen receptors (CARs) have been used to redirect the specificity of autologous T cells against leukemia and lymphoma with promising clinical results. Extending this approach to allogeneic T cells is problematic as they carry a …